Create Alert
Watchlist

Bafna Pharmaceuticals

₹149.68
+2.93 (2.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
149.68
Prev. Close
146.75
Volume
6,239
Total traded value
0.09 Cr
Upper Circuit
149.68
Lower Circuit
143.82

Fundamentals

Market Cap₹350Cr
ROE11.59%
P/E Ratio(TTM)39.89
EPS(TTM)3.71
P/B Ratio3.84
Dividend Yield0.00%
Industry P/E39.81
Book Value38.56
Debt to Equity0.36
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited is engaged in manufacturing pharmaceutical formulations and is also a recognized player in the Contract Research and Manufacturing Services (CRAMS) industry. Looking forward, the company is focused on capturing growth opportunities in specialized areas like personalized medicine, biologics, and advanced drug delivery systems. Its unwavering commitment to excellence has led to the successful creation of several new formulations, expanding its product range across all segments. The company's manufacturing facility is certified by international bodies like EU GMP, UK MHRA, and TGA Australia for producing solid oral medicines. A key part of its strategy is to increase income from globally registered products while also applying for new registrations to create more opportunities. Bafna Pharmaceuticals successfully exports its products to major international markets including Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth nations.;
Parent OrganisationBafna Pharmaceuticals
Managing DirectorBafna Mahaveer Chand
Founded1995
NSE SymbolBAFNAPH

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
75.00%
Retail And Others
15.66%
Foreign Institutions
9.34%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
59.46
Ajanta Pharma
NA
(0.00%)
33.38
Gland Pharma
NA
(0.00%)
34.73
Eris Lifesciences
NA
(0.00%)
47.12
2025
11
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date
26
May
Annual Result
Release date
6
Feb
Quarterly Result
Release date
2024
11
Nov
Quarterly Result
Release date
13
Aug
Quarterly Result
Release date
29
May
Result
Release date
Events calendar
View upcoming events in other stocks